<DOC>
	<DOCNO>NCT00322075</DOCNO>
	<brief_summary>Comparison incidence hypoglycaemic event glycaemic fluctuation diabetic patient basal substitution NPH insuline versus insuline glargine . Evaluation HbA1c , FBG ( Fasting Blood Glucose ) , BMI ( Body Mass Index ) , dose insulin , ratio basal prandial insulin , satisfaction treatment , incidence adverse event .</brief_summary>
	<brief_title>LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Patients Diabetes Mellitus Type 1 Diabetes Mellitus Type 2 HbA1c 6 % 2 confirmed hypoglycaemic event ( glycaemia le 3,3 mmol/l ) last year Diabetic ketoacidosis Any severe disease Pregnancy fertile female without contraception Alcohol/drug abuse , select prohibit concomitant medication Nightshift work</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>